Echinocandin resistance in human pathogenic fungi

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 2, 2012, Pages 115-116

  Munro, Carol A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

antifungal; Candida albicans; chitin; glucan

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLOSPORIN A; ECHINOCANDIN; TACROLIMUS;

ANTIFUNGAL RESISTANCE; ASPERGILLUS; BLOODSTREAM INFECTION; CANDIDA; CANDIDIASIS; DRUG MECHANISM; DRUG POTENTIATION; EDITORIAL; ENZYME ACTIVITY; FUNGAL VIRULENCE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MYCOSIS; SIGNAL TRANSDUCTION;

ANTIFUNGAL AGENTS; ASPERGILLUS; CALCINEURIN; CANDIDA; CELL WALL; CHITIN; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MYCOSES; SIGNAL TRANSDUCTION;

EID: 84857520947     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.171     Document Type: Editorial

References (19)

1. Pfaller MA. Epidemiology of candidiasis. J. Hosp. Infect. 30(Suppl.), 329-338 (1995).
2. Denning DW. Echinocandin antifungal drugs. Lancet 362(9390), 1142-1151 (2003).
3. Perlin DS. Current perspectives on echinocandin class drugs. Future Microbiol. 6(4), 441-457 (2011).
4. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10(3), 121-130 (2007).
5. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int. J. Antimicrob. Agents 38(1), 65-69 (2011).
6. Walker LA, Gow NA, Munro CA. Fungal echinocandin resistance. Fungal Genet. Biol. 47(2), 117-126 (2010).
7. Garcia-Effron G, Park S, Perlin DS. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob. Agents Chemother. 53(1), 112-122 (2009).
8. Cowen LE , Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot. Cell 7(5), 747-764 (2008).
9. Fortwendel JR, Juvvadi PR, Pinchai N et al. Differential effects of inhibiting chitin and 1,3-β-d-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob. Agents Chemother. 53(2), 476-482 (2009).
10. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 5(7), e1000532 (2009).
11. Chen YL, Brand A, Morrison EL et al. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryot. Cell 10(6), 803-819 (2011).
12. Miyazaki T, Yamauchi S, Inamine T et al. Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata. Antimicrob. Agents Chemother. 54(4), 1639-1643 (2010).
13. Cowen LE. Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathog. 5(8), e1000471 (2009).
14. Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA. Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog. 4(4), e1000040 (2008).
15. Munro CA, Gow NA. Chitin synthesis in human pathogenic fungi. Med. Mycol. 39(Suppl. 1), 41-53 (2001).
16. Levin DE. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 69(2), 262-291 (2005).
17. Popolo L, Gualtieri T, Ragni E. The yeast cell-wall salvage pathway. Med. Mycol. 39(S1), 111-121 (2001).
18. Lee KK, MacCallum DM, Jacobsen MD et al. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob. Agents Chemother. 56(1), 208-217 (2012).
19. Ben Ami R, Garcia-Effron G, Lewis RE et al. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J. Infect. Dis. 204(4), 626-635 (2011).